TrialClinical pharmacology in drug development2021

First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator.

Ying Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.